Will prasugrel supersede clopidogrel for acute coronary syndromes?

Med J Aust. 2008 Apr 7;188(7):381-2. doi: 10.5694/j.1326-5377.2008.tb01678.x.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • Acute Coronary Syndrome / drug therapy*
  • Acute Coronary Syndrome / mortality
  • Acute Coronary Syndrome / therapy
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Aspirin / therapeutic use
  • Clopidogrel
  • Coronary Artery Bypass
  • Hemorrhage / chemically induced
  • Humans
  • Piperazines / adverse effects
  • Piperazines / therapeutic use*
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Prasugrel Hydrochloride
  • Randomized Controlled Trials as Topic
  • Risk Factors
  • Thiophenes / adverse effects
  • Thiophenes / therapeutic use*
  • Ticlopidine / adverse effects
  • Ticlopidine / analogs & derivatives*
  • Ticlopidine / therapeutic use

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Piperazines
  • Platelet Aggregation Inhibitors
  • Thiophenes
  • Clopidogrel
  • Prasugrel Hydrochloride
  • Ticlopidine
  • Aspirin